TREM2 Haplodeficiency in Mice and Humans Impairs the Microglia Barrier Function Leading to Decreased Amyloid Compaction and Severe Axonal Dystrophy

Yuan, Peng, Condello, Carlo, Keene, C. Dirk, Wang, Yaming, Bird, Thomas D., Paul, Steven M., Luo, Wenjie, Colonna, Marco, Baddeley, David, Grutzendler, Jaime·2016·Neuron
DOI 10.1016/j.neuron.2016.05.003

Cited by (146)

Items 101–146 of 146

  1. Glia in neurodegeneration: Drivers of disease or along for the ride?
    Gleichman, Amy J., Carmichael, S. Thomas · 2020 · Neurobiology of Disease
  2. The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer's disease
    Moutinho, Miguel, Puntambekar, Shweta S., Tsai, Andy P., Coronel, Israel, Lin, Peter B., Casali, Brad T., Martinez, Pablo, Oblak, Adrian L., Lasagna-Reeves, Cristian A., Lamb, Bruce T. et al. · 2022 · Science Translational Medicine
  3. Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal model
    Wang, Hong, Li, Yupeng, Ryder, John W., Hole, Justin T., Ebert, Philip J., Airey, David C., Qian, Hui-Rong, Logsdon, Benjamin, Fisher, Alice, Ahmed, Zeshan et al. · 2018 · Molecular Neurodegeneration
  4. Shifting paradigms: The central role of microglia in Alzheimer’s disease
    Schwabe, Tina, Srinivasan, Karpagam, Rhinn, Herve · 2020 · Neurobiology of Disease
  5. Integrative approach to sporadic Alzheimer’s disease: deficiency of TYROBP in cerebral Aβ amyloidosis mouse normalizes clinical phenotype and complement subnetwork molecular pathology without reducing Aβ burden
    Haure-Mirande, Jean-Vianney, Wang, Minghui, Audrain, Mickael, Fanutza, Tomas, Kim, Soong Ho, Heja, Szilvia, Readhead, Ben, Dudley, Joel T., Blitzer, Robert D., Schadt, Eric E. et al. · 2019 · Molecular Psychiatry
  6. Current trends in blood biomarker detection and imaging for Alzheimer’s disease
    Hu, Shun, Yang, Changwen, Luo, Haiming · 2022 · Biosensors and Bioelectronics
  7. Plaque-associated myeloid cells derive from resident microglia in an Alzheimer's disease model
    Reed-Geaghan, Erin G., Croxford, Andrew L., Becher, Burkhard, Landreth, Gary E. · 2020 · Journal of Experimental Medicine
  8. Microglial INPP5D limits plaque formation and glial reactivity in the PSAPP mouse model of Alzheimer's disease
    Castranio, Emilie L., Hasel, Philip, Haure‐Mirande, Jean‐Vianney, Ramirez Jimenez, Angie V., Hamilton, B. Wade, Kim, Rachel D., Glabe, Charles G., Wang, Minghui, Zhang, Bin, Gandy, Sam et al. · 2023 · Alzheimer's & Dementia
  9. The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
    AmeliMojarad, Melika, AmeliMojarad, Mandana · 2024 · CNS Neuroscience & Therapeutics
  10. Microglial repopulation reverses cognitive and synaptic deficits in an Alzheimer’s disease model by restoring BDNF signaling
    Wang, Wanbing, Li, Yanzhong, Ma, Fangling, Sheng, Xuan, Chen, Kai, Zhuo, Rengong, Wang, Chen, Zheng, Honghua, Zhang, Yun-wu, Bu, Guojun et al. · 2023 · Brain, Behavior, and Immunity
  11. Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer’s disease
    Tsai, Andy P., Dong, Chuanpeng, Lin, Peter Bor-Chian, Oblak, Adrian L., Viana Di Prisco, Gonzalo, Wang, Nian, Hajicek, Nicole, Carr, Adam J., Lendy, Emma K., Hahn, Oliver et al. · 2023 · Immunity
  12. The VCAM1–ApoE pathway directs microglial chemotaxis and alleviates Alzheimer’s disease pathology
    Lau, Shun-Fat, Wu, Wei, Wong, Hiu Yi, Ouyang, Li, Qiao, Yi, Xu, Jiahui, Lau, Jessica Hiu-Yan, Wong, Carlton, Jiang, Yuanbing, Holtzman, David M. et al. · 2023 · Nature Aging
  13. Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice
    Fitz, Nicholas F., Wolfe, Cody M., Playso, Brittany E., Biedrzycki, Richard J., Lu, Yi, Nam, Kyong Nyon, Lefterov, Iliya, Koldamova, Radosveta · 2020 · Molecular Neurodegeneration
  14. Galectin-3 is elevated in CSF and is associated with Aβ deposits and tau aggregates in brain tissue in Alzheimer’s disease
    Boza-Serrano, Antonio, Vrillon, Agathe, Minta, Karolina, Paulus, Agnes, Camprubí-Ferrer, Lluís, Garcia, Megg, Andreasson, Ulf, Antonell, Anna, Wennström, Malin, Gouras, Gunnar et al. · 2022 · Acta Neuropathologica
  15. Reducing microglial lipid load enhances β amyloid phagocytosis in an Alzheimer’s disease mouse model
    Wu, Xiaoting, Miller, James Alastair, Lee, Bernett Teck Kwong, Wang, Yulan, Ruedl, Christiane · 2025 · Science Advances
  16. Microglia: Friend and foe in tauopathy
    Odfalk, Kristian F., Bieniek, Kevin F., Hopp, Sarah C. · 2022 · Progress in Neurobiology
  17. Modulation of β-Amyloid Fibril Formation in Alzheimer’s Disease by Microglia and Infection
    Brown, Madeleine R., Radford, Sheena E., Hewitt, Eric W. · 2020 · Frontiers in Molecular Neuroscience
  18. TREM2/PLCγ2 signalling in immune cells: function, structural insight, and potential therapeutic modulation
    Magno, Lorenza, Bunney, Tom D., Mead, Emma, Svensson, Fredrik, Bictash, Magda N. · 2021 · Molecular Neurodegeneration
  19. Rare TREM2 variants associated with Alzheimer’s disease display reduced cell surface expression
    Sirkis, Daniel W., Bonham, Luke W., Aparicio, Renan E., Geier, Ethan G., Ramos, Eliana Marisa, Wang, Qing, Karydas, Anna, Miller, Zachary A., Miller, Bruce L., Coppola, Giovanni et al. · 2016 · Acta Neuropathologica Communications
  20. Deletion of Abi3 gene locus exacerbates neuropathological features of Alzheimer’s disease in a mouse model of Aβ amyloidosis
    Karahan, Hande, Smith, Daniel C., Kim, Byungwook, Dabin, Luke C., Al-Amin, Md Mamun, Wijeratne, H. R. Sagara, Pennington, Taylor, Viana di Prisco, Gonzalo, McCord, Brianne, Lin, Peter Bor-chian et al. · 2021 · Science Advances
  21. Therapeutic targeting of immunometabolism reveals a critical reliance on hexokinase 2 dosage for microglial activation and Alzheimer’s progression
    Codocedo, Juan F., Mera-Reina, Claudia, Bor-Chian Lin, Peter, Fallen, Paul B., Puntambekar, Shweta S., Casali, Brad T., Jury-Garfe, Nur, Martinez, Pablo, Lasagna-Reeves, Cristian A., Landreth, Gary E. · 2024 · Cell Reports
  22. Microglia in Alzheimer's Disease: a Key Player in the Transition Between Homeostasis and Pathogenesis
    McFarland, Karen N., Chakrabarty, Paramita · 2022 · Neurotherapeutics
  23. Microglia in Health and Diseases: Integrative Hubs of the Central Nervous System (CNS)
    Sierra, Amanda, Miron, Veronique E., Paolicelli, Rosa C., Ransohoff, Richard M. · 2024 · Cold Spring Harbor Perspectives in Biology
  24. Genetic risk factors for Alzheimer disease: emerging roles of microglia in disease pathomechanisms
    Takatori, Sho, Wang, Wenbo, Iguchi, Akihiro, Tomita, Taisuke · 2019 · Advances in Experimental Medicine and Biology
  25. The effect of aged microglia on synaptic impairment and its relevance in neurodegenerative diseases
    Triviño, Juan José, von Bernhardi, Rommy · 2021 · Neurochemistry International
  26. Regulation of cell distancing in peri-plaque glial nets by Plexin-B1 affects glial activation and amyloid compaction in Alzheimer’s disease
    Huang, Yong, Wang, Minghui, Ni, Haofei, Zhang, Jinglong, Li, Aiqun, Hu, Bin, Junqueira Alves, Chrystian, Wahane, Shalaka, Rios de Anda, Mitzy, Ho, Lap et al. · 2024 · Nature Neuroscience
  27. The most prevalent rare coding variants of TREM2 conferring risk of Alzheimer's disease: A systematic review and meta‑analysis
    Li, Rong, Wang, Xia, He, Pengfei · 2021 · Experimental and Therapeutic Medicine
  28. TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism
    Feiten, Astrid F., Dahm, Kilian, Schlepckow, Kai, van Lengerich, Bettina, Suh, Jung H., Reifschneider, Anika, Wefers, Benedikt, Bartos, Laura M., Wind-Mark, Karin, de Weerd, Lis et al. · 2026 · Nature Communications
  29. INPP5D modulates TREM2 loss-of-function phenotypes in a β-amyloidosis mouse model
    Iguchi, Akihiro, Takatori, Sho, Kimura, Shingo, Muneto, Hiroki, Wang, Kai, Etani, Hayato, Ito, Genta, Sato, Haruaki, Hori, Yukiko, Sasaki, Junko et al. · 2023 · iScience
  30. The dense-core plaques of Alzheimer’s disease are granulomas
    Lemke, Greg, Huang, Youtong · 2022 · Journal of Experimental Medicine
  31. Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple Sclerosis
    Etxeberria, Ainhoa, Shen, Yun-An A., Vito, Stephen, Silverman, Sean M., Imperio, Jose, Lalehzadeh, Guita, Soung, Allison L., Du, Changchun, Xie, Luke, Choy, Man Kin et al. · 2024 · The Journal of Neuroscience
  32. Integrated approach reveals diet, APOE genotype and sex affect immune response in APP mice
    Nam, Kyong Nyon, Wolfe, Cody M., Fitz, Nicholas F., Letronne, Florent, Castranio, Emilie L., Mounier, Anais, Schug, Jonathan, Lefterov, Iliya, Koldamova, Radosveta · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  33. Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation
    Takeda, Keisuke, Uda, Aoi, Mitsubori, Mikihiro, Nagashima, Shun, Iwasaki, Hiroko, Ito, Naoki, Shiiba, Isshin, Ishido, Satoshi, Matsuoka, Masaaki, Inatome, Ryoko et al. · 2021 · Communications Biology
  34. THY-Tau22 mouse model accumulates more tauopathy at late stage of the disease in response to microglia deactivation through TREM2 deficiency
    Vautheny, Audrey, Duwat, Charlotte, Aurégan, Gwennaëlle, Joséphine, Charlène, Hérard, Anne-Sophie, Jan, Caroline, Mitja, Julien, Gipchtein, Pauline, Gaillard, Marie-Claude, Buée, Luc et al. · 2021 · Neurobiology of Disease
  35. Emergence of distinct and heterogeneous strains of amyloid beta with advanced Alzheimer’s disease pathology in Down syndrome
    Maxwell, Alison M., Yuan, Peng, Rivera, Brianna M., Schaaf, Wilder, Mladinov, Mihovil, Prasher, Vee P., Robinson, Andrew C., DeGrado, William F., Condello, Carlo · 2021 · Acta Neuropathologica Communications
  36. EMBER multidimensional spectral microscopy enables quantitative determination of disease- and cell-specific amyloid strains
    Yang, Hyunjun, Yuan, Peng, Wu, Yibing, Shi, Marie, Caro, Christoffer D., Tengeiji, Atsushi, Yamanoi, Shigeo, Inoue, Masahiro, DeGrado, William F., Condello, Carlo · 2023 · Proceedings of the National Academy of Sciences
  37. Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer’s disease
    Jury-Garfe, Nur, Redding-Ochoa, Javier, You, Yanwen, Martínez, Pablo, Karahan, Hande, Chimal-Juárez, Enrique, Johnson, Travis S., Zhang, Jie, Resnick, Susan, Kim, Jungsu et al. · 2024 · Acta Neuropathologica
  38. A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells
    Varnum, Megan M., Clayton, Kevin A., Yoshii-Kitahara, Asuka, Yonemoto, Grant, Koro, Lacin, Ikezu, Seiko, Ikezu, Tsuneya · 2017 · Journal of Biological Chemistry
  39. TREM2-Deficient Microglia Attenuate Tau Spreading In Vivo
    Lee-Gosselin, Audrey, Jury-Garfe, Nur, You, Yanwen, Dabin, Luke, Soni, Disha, Dutta, Sayan, Rochet, Jean-Christophe, Kim, Jungsu, Oblak, Adrian L., Lasagna-Reeves, Cristian A. · 2023 · Cells
  40. PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology
    Messenger, Evan J., Baar, Sydney A., Bedford, Logan M., Tsai, Andy P., Lin, Peter Bor‐Chian, Ferguson, Chloe A., Xu, Guixiang, Wallace, Abigail, Landreth, Gary E., Lamb, Bruce T. et al. · 2025 · Alzheimer's & Dementia
  41. The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions
    Takalo, Mari, Jeskanen, Heli, Rolova, Taisia, Kervinen, Inka, Hellén, Marianna, Heikkinen, Sami, Koivisto, Hennariikka, Jokivarsi, Kimmo, Müller, Stephan A., Koivumäki, Esa-Mikko et al. · 2025 · Journal of Neuroinflammation
  42. TREM2 and microglial immunity in Alzheimer’s disease: mechanisms, genetics, and therapeutic opportunities
    Wang, Tianqing, Liu, Xinru, Wang, Xifeng, Hua, Fuzhou, Yan, Lei · 2026 · Frontiers in Immunology
  43. Mouse and human microglial phenotypes in Alzheimer’s disease are controlled by amyloid plaque phagocytosis through Hif1α
    Grubman, Alexandra, Choo, Xin Yi, Chew, Gabriel, Ouyang, John F., Sun, Guizhi, Croft, Nathan P., Rossello, Fernando J., Simmons, Rebecca, Buckberry, Sam, Landin, Dulce Vargas et al. · 2019
  44. Alzheimer's Protection by PLCγ2 Compacts Plaques, Redistributes Microglia, and Protects Synapses in App NL ‐G‐F Mice
    Bevan, Ryan J., Maguire, Emily, Mackinnon, Eilish, Salis, Elisa, Phillips, Thomas, Simonazzi, Elena, Vassileva, Marieta, Allen, Nicholas D., Williams, Julie, Taylor, Philip R. · 2026 · Glia
  45. APOE2 attenuates APOE4-associated amyloid pathology and related toxicity in a mouse model of Alzheimer’s disease
    Chen, Kai, Chen, Yixing, Ren, Yingxue, Wang, Zhen, Huang, Ya, Pan, Meixia, Li, Zonghua, Casey, Monica Castanedes, Qiao, Wenhui, Shi, Ji et al. · 2026 · Nature Communications
  46. Alzheimer’s genetic risk factor CASS4 controls microglial focal adhesion biology and amyloidosis
    Walsh, Adeline E., Davis, Benjamin A., Samuels, Joshua D., Mills, William A., Thanos, Jessica M., Johnson, Alexis M., Moore, Katelyn A., Puchalski, Michael A., Steacy, Eric J., Wendell, Benjamin W. et al. · 2026 · Journal of Experimental Medicine